Logo

iSchemaView

For more than 20 years, most believed that doctors had only a few hours after a stroke to provide treatment. But we were never satisfied with that thinking. iSchemaView Co-Founders Dr. Greg Albers and Dr. Roland Bammer were determined to expand the treatment window for stroke. Working together over a decade ago, they theorized that stroke evolution was highly variable, and that the conventional short treatment windows could be upended and far more people with cerebrovascular disorders could be saved.

The technology available at that time to process perfusion imaging studies was cumbersome, time-consuming, and poorly validated. Dr. Albers and Dr. Bammer partnered with software engineer Matus Straka and Silicon Valley venture capitalist Don Valentine to address these limitations. They developed RAPID (Rapid Processing of Perfusion and Diffusion), a fully automated image processing platform to provide accurate and reliable imaging processing that could be performed using data from any CT or MRI scanner.

Company specifications

General
Company name iSchemaView
Founded 2006
Head office Redwood City, United States
Website https://www.rapidai.com/
Contact

Products by this company

Logo
Subspeciality: Neuro
Modality: CT

automated ASPECT scoring

Based on the Alberta Stroke Program Early CT Scoring System, Rapid ASPECTS automatically generates a standardized score—based on machine-learning algorithms showing a patient’s ischemic ...

CE: Logo
FDA: Logo
Information source:
Public
Certification verified:
No
Logo
Subspeciality: Neuro
Modality: CT
CE: Logo
FDA: Logo
Information source:
Public
Certification verified:
No
Logo
Subspeciality: Neuro
Modality: CT
CE: Logo
FDA: Logo
Information source:
Public
Certification verified:
No
Logo
Subspeciality: Neuro
Modality: CT
CE: Logo
FDA: Logo
Information source:
Public
Certification verified:
No
Logo
Subspeciality: Neuro
Modality: MR
CE: Logo
FDA: Logo
Information source:
Public
Certification verified:
No